KNSA logo

Kiniksa Pharmaceuticals (KNSA) Net Income

Annual Net Income

$14.08 M
-$169.28 M-92.32%

December 31, 2023

Summary

Performance

1-Year Change

-92.32%

3-Year Change

+108.73%

5-Year Change

+113.64%

15-Year Change

+121.71%

KNSA Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

86.51%
KNSA annual net profit is higher than 86.51% of companies in Healthcare sector

High & Low

All-time High

$183.36 M
KNSA annual net profit is currently -92.32% below its historical high of $183.36 million

3-Year Low

-$157.92 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
KNSA previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
KNSA next annual earnings announcement is scheduled for Feb 28, 2025

OtherKNSAprofitabilitymetrics:

Annual Net Margin

5.21%
KNSA annual net profit margin is 5.21%

Annual Revenue

$270.26 M
KNSA annual revenue is $270.26 million

Annual Gross Profit

$236.85 M
KNSA annual gross profit is $236.85 million

Annual EPS

$0.20
KNSA annual earnings per share is $0.20

Quarterly Net Income

-$12.69 M
-$8.79 M-224.80%

September 30, 2024

Summary

Performance

3-Month Change

-224.8%

1-Year Change

+8.39%

3-Year Change

+58.44%

5-Year Change

+53.09%

KNSA Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.91%
KNSA quarterly net profit is higher than 35.91% of companies in Healthcare sector

High & Low

All-time High

$224.09 M
KNSA quarterly net profit is currently -105.66% below its historical high of $224.09 million

3-Year Low

-$36.33 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
KNSA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
KNSA next earnings announcement is scheduled for Feb 28, 2025

OtherKNSAprofitabilitymetrics:

Quarterly Net Margin

-11.31%
KNSA quarterly net profit margin is -11.31%

Quarterly Revenue

$112.21 M
KNSA quarterly revenue is $112.21 million

Quarterly Gross Profit

$62.80 M
KNSA quarterly gross profit is $62.80 million

Quarterly EPS

-$0.18
KNSA quarterly earnings per share is -$0.18

TTM Net Income

-$9.07 M
+$1.16 M+11.36%

September 30, 2024

Summary

Performance

3-Month Change

+11.36%

1-Year Change

-35.51%

3-Year Change

+94.83%

5-Year Change

+94.4%

KNSA TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

70.39%
KNSA TTM net profit is higher than 70.39% of companies in Healthcare sector

High & Low

All-time High

$231.26 M
KNSA TTM net profit is currently -103.92% below its historical high of $231.26 million

3-Year Low

-$157.92 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
KNSA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
KNSA next earnings announcement is scheduled for Feb 28, 2025

OtherKNSAprofitabilitymetrics:

Annual Net Margin

5.21%
KNSA annual net profit margin is 5.21%

TTM Revenue

$384.10 M
KNSA TTM revenue is $384.10 million

TTM Gross Profit

$290.96 M
KNSA TTM gross profit is $290.96 million

TTM EPS

-$0.14
KNSA TTM earnings per share is -$0.14

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

$14.08 M
KNSA annual net profit is $14.08 million

Annual Revenue

$270.26 M
KNSA annual revenue is $270.26 million

Annual Cost Of Goods Sold

$33.41 M
KNSA annual cost of goods sold is $33.41 million

Annual Operating Expenses

$205.52 M
KNSA annual total operating expenses is $205.52 million

Annual Interest Expense

-
KNSA annual interest expense value is unknown

Annual Income Tax

-$30.74 M
KNSA annual income tax is -$30.74 million

KNSA Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-92.3%+8.4%-35.5%
3 y3 years+108.7%+58.4%+94.8%
5 y5 years+113.6%+53.1%+94.4%

KNSA Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-92.3%+108.9%-105.7%+65.1%-103.9%+94.3%
5 y5-year-92.3%+108.7%-105.7%+76.3%-103.9%+95.2%
alltimeall time-92.3%+108.7%-105.7%+80.7%-103.9%+95.2%

Kiniksa Pharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$12.69 M(+224.8%)
-$9.07 M(-11.4%)
Jun 2024
-
-$3.91 M(-77.9%)
-$10.23 M(-218.3%)
Mar 2024
-
-$17.70 M(-170.2%)
$8.65 M(-38.6%)
Dec 2023
$14.08 M(-92.3%)
$25.24 M(-282.2%)
$14.08 M(-310.5%)
Sep 2023
-
-$13.86 M(-192.5%)
-$6.69 M(-102.9%)
Jun 2023
-
$14.97 M(-222.0%)
$231.26 M(+17.8%)
Mar 2023
-
-$12.27 M(-375.1%)
$196.30 M(+7.1%)
Dec 2022
$183.36 M(-216.1%)
$4.46 M(-98.0%)
$183.36 M(+28.6%)
Sep 2022
-
$224.09 M(-1221.5%)
$142.57 M(-227.2%)
Jun 2022
-
-$19.98 M(-20.7%)
-$112.07 M(-16.1%)
Mar 2022
-
-$25.21 M(-30.6%)
-$133.65 M(-15.4%)
Dec 2021
-$157.92 M(-2.1%)
-$36.33 M(+19.0%)
-$157.92 M(-9.9%)
Sep 2021
-
-$30.54 M(-26.5%)
-$175.25 M(-7.0%)
Jun 2021
-
-$41.56 M(-16.0%)
-$188.54 M(+2.2%)
Mar 2021
-
-$49.48 M(-7.8%)
-$184.45 M(+14.3%)
Dec 2020
-$161.38 M
-$53.66 M(+22.4%)
-$161.38 M(+15.7%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$43.84 M(+17.0%)
-$139.52 M(+13.7%)
Jun 2020
-
-$37.47 M(+41.8%)
-$122.74 M(+0.2%)
Mar 2020
-
-$26.42 M(-16.9%)
-$122.47 M(-24.3%)
Dec 2019
-$161.87 M(+56.8%)
-$31.80 M(+17.5%)
-$161.87 M(-6.2%)
Sep 2019
-
-$27.06 M(-27.2%)
-$172.65 M(+1.6%)
Jun 2019
-
-$37.19 M(-43.5%)
-$170.00 M(+11.1%)
Mar 2019
-
-$65.82 M(+54.6%)
-$153.07 M(+48.3%)
Dec 2018
-$103.23 M(+59.1%)
-$42.58 M(+74.5%)
-$103.23 M(+10.6%)
Sep 2018
-
-$24.41 M(+20.5%)
-$93.35 M(+9.9%)
Jun 2018
-
-$20.26 M(+26.8%)
-$84.97 M(+11.9%)
Mar 2018
-
-$15.98 M(-51.1%)
-$75.92 M(+17.0%)
Dec 2017
-$64.87 M(+170.6%)
-$32.70 M(+104.0%)
-$64.87 M(+101.6%)
Sep 2017
-
-$16.03 M(+43.1%)
-$32.17 M(+99.3%)
Jun 2017
-
-$11.20 M(+126.7%)
-$16.14 M(+226.7%)
Mar 2017
-
-$4.94 M
-$4.94 M
Dec 2016
-$23.97 M
-
-

FAQ

  • What is Kiniksa Pharmaceuticals annual net profit?
  • What is the all time high annual net income for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals annual net income year-on-year change?
  • What is Kiniksa Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals quarterly net income year-on-year change?
  • What is Kiniksa Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals TTM net income year-on-year change?

What is Kiniksa Pharmaceuticals annual net profit?

The current annual net income of KNSA is $14.08 M

What is the all time high annual net income for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high annual net profit is $183.36 M

What is Kiniksa Pharmaceuticals annual net income year-on-year change?

Over the past year, KNSA annual net profit has changed by -$169.28 M (-92.32%)

What is Kiniksa Pharmaceuticals quarterly net profit?

The current quarterly net income of KNSA is -$12.69 M

What is the all time high quarterly net income for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high quarterly net profit is $224.09 M

What is Kiniksa Pharmaceuticals quarterly net income year-on-year change?

Over the past year, KNSA quarterly net profit has changed by +$1.16 M (+8.39%)

What is Kiniksa Pharmaceuticals TTM net profit?

The current TTM net income of KNSA is -$9.07 M

What is the all time high TTM net income for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high TTM net profit is $231.26 M

What is Kiniksa Pharmaceuticals TTM net income year-on-year change?

Over the past year, KNSA TTM net profit has changed by -$2.38 M (-35.51%)